PMV PHARMACEUTICALS INC (PMVP)
US69353Y1038 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -51.46M | -68.96M | -73.32M | -57.85M | -34.44M | |||
| Depreciation Amortization | 1.46M | 1.26M | 320.00K | 310.00K | 320.00K | |||
| Change In Working Capital | -730.00K | 5.43M | -570.00K | 4.12M | -850.00K | |||
| Taxes Paid | N/A | 0.00 | 0.00 | 20.00K | 10.00K | |||
| Other non cash items | 4.02M | 6.62M | 9.81M | 6.85M | 2.23M | |||
| OPERATING CASH FLOW | -46.71M | -55.66M | -63.76M | -46.57M | -32.74M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -791.00K | -962.00K | -7.98M | -1.35M | -150.00K | |||
| Other Investing Activity | 43.81M | -49.58M | 6.62M | -142.24M | 28.06M | |||
| INVESTING CASH FLOW | 43.02M | -50.55M | -1.37M | -143.58M | 27.91M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 428.00K | 35.58M | 960.00K | 2.02M | 292.97M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 428.00K | 35.58M | 960.00K | 2.02M | 292.97M | |||
| Exchange Rate Effect | N/A | 34.00K | N/A | N/A | N/A | |||
| CHANGE IN CASH | -3.25M | -70.59M | -64.17M | -188.13M | 288.14M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -46.71M | -55.66M | -63.76M | -46.57M | -32.74M | |||
| Capital Expenditure | -791.00K | -962.00K | -7.98M | -1.35M | -150.00K | |||
| FREE CASH FLOW | -47.50M | -56.62M | -71.74M | -47.92M | -32.89M | |||
All data in USD